Sun Pharma talks with Meda hit valuation obstacle

India’s Sun Pharmaceuticals’ talks to acquire Swedish drugmaker Meda are foundering over differences over valuation. According to a Reuters report, several banks were willing to provide Sun Pharma with funding…